The result demonstrates that ccRCC patients with low AOX1 mRNA expression levels had worse overall survival than those with high AOX1 mRNA expression levels [high expression vs. low expression hazard ratio (HR): 0.52, 95% CI: 0.38–0.72] (Figure 5A). This evidence concerns the gene AOX1 and nonpapillary renal cell carcinoma.